Form 4 for RGEN REPLIGEN CORP
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-11 · accession 0000899243-22-035725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-14 | 2022-11-11 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $33.87 | +25.0K | 203.3K | +14% | +$846.7K |
| D | 2022-11-14 | 2022-11-11 | RGEN | Hunt Anthony | CEO, Dir | S - Sale+OE | $200.00 | -25.0K | 178.3K | -12% | -$5.00M |
| D | 2022-11-14 | 2022-11-11 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $0.00 | +25.0K | 34.2K | +270% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | M | A | 25,000 | $33.87 | 203,265 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-11 | S | D | 25,000 | $200.00 | 178,265 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-11-11 | M | A | 25,000 | $0.00 | 34,246 | D | $33.87 · — to 2028-02-29 | 25,000 Common Stock | (F2) This option is fully vested and exercisable. |